Skip to content

Released Nov 14, 2012, during market hours

10-Q filed Nov 14, 2012, 45 days after period end · 0001144204-12-062448

Q3 2012 · 10-Q
Revenue$5.42M+6.5% vs Q3 2011+185.9% vs Q2 2012
Net Income$1.07M−3.2% vs Q3 2011N/M vs Q2 2012
EPS Diluted$0.07±0.0% vs Q3 2011−46.2% vs Q2 2012
Gross Profit$3,399,000−5.5%
Operating Income$1,073,000−3.0%
Operating Cash Flowderived-$2,694,000N/M
Free Cash Flowderived-$2,795,000N/M
Margins · derived
Gross margin62.8%−8.0 pt vs Q3 2011
Operating margin19.8%−1.9 pt vs Q3 2011
Net margin19.8%−2.0 pt vs Q3 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2012Q3 2011Q3 2010
Revenue$5.42M$5.08M$5.20M
Net Income$1.07M$1.11M$947.00K
EPS Diluted$0.07$0.07$0.06

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR